Does Baseline Prostate Volume Affect the Short-Term Outcome of Tamsulosin?
| Autor: | Taiji Tsukamoto, Kenichi Sunaoshi, Yoshinori Tanaka, Noriomi Miyao, Eiji Sato, Naoya Masumori, Hiroki Horita, Koh Takeyama |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
medicine.medical_specialty
business.industry Urology medicine.medical_treatment Significant difference medicine.disease Affect (psychology) Alpha-1 blocker medicine.anatomical_structure Neurology Quality of life Tamsulosin Lower urinary tract symptoms Prostate medicine Baseline (configuration management) business medicine.drug |
| Zdroj: | LUTS: Lower Urinary Tract Symptoms. 6:113-116 |
| ISSN: | 1757-5664 |
| Popis: | Objective To investigate the short-term efficacy of tamsulosin treatment for patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) according to baseline prostate volume (PV). Methods Tamsulosin, 0.2 mg/day, was prospectively given to 112 patients aged 50 years or older who had International Prostate Symptom Scores (IPSS) ≥ 8. The short-term efficacy was analyzed using the IPSS, quality of life (QOL) index, BPH problem index (BPI), maximum flow rate (Qmax) and postvoid residual urine volume (PVR) at 4 weeks and 3 months after treatment considering the estimated PV at baseline. Results Of the 112 patients, 81 and 31 had PV of |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text